Agency Information Collection Activities: Submission for OMB Review; Comment Request, 48931-48932 [E6-13847]

Download as PDF cprice-sewell on PROD1PC66 with NOTICES Federal Register / Vol. 71, No. 162 / Tuesday, August 22, 2006 / Notices General Function of the Committee: To provide advice and recommendations to the agency on FDA’s regulatory issues. Date and Time: The meeting will be held on September 19, 2006, from 8 a.m. to 5:30 p.m. Location: Hilton Washington DC North/Gaithersburg, Salons C, D and E, 620 Perry Parkway, Gaithersburg, MD. Contact Person: Ronald P. Jean, Center for Devices and Radiological Health (HFZ–410), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301–594–2036, ext. 181, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), code 3014512521. Please call the Information Line for up-to-date information on this meeting. Agenda: The committee will discuss, make recommendations and vote on a premarket approval application for a cervical disc prosthesis intended to treat skeletally mature patients with degenerative disc disease at one level from C3–C7. Background information for the topics, including the agenda and questions for the committee, will be available to the public 1 business day before the meeting on the Internet at http://www.fda.gov/cdrh/panel (click on Upcoming CDRH Advisory Panel/ Committee Meetings). Procedure: On September 19, 2006, from 8:30 a.m. to 5:30 p.m., the meeting will be open to the public. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before September 5, 2006. Oral presentations from the public will be scheduled for 30 minutes at the beginning of the committee deliberations and for 30 minutes near the end of the deliberations. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before September 5, 2006. Closed Committee Deliberations: On September 19, 2006, from 8 a.m. to 8:30 a.m., the meeting will be closed to permit FDA to present to the committee trade secret and/or confidential commercial information (5 U.S.C. 552b(c)(4)) relating to pending issues and applications. Persons attending FDA’s advisory committee meetings are advised that the VerDate Aug<31>2005 15:34 Aug 21, 2006 Jkt 208001 agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Shirley Meeks, Conference Management Staff, at 301–827–7292, least 7 days in advance of the meeting. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: August 14, 2006. Randall W. Lutter, Associate Commissioner for Policy and Planning. [FR Doc. E6–13823 Filed 8–21–06; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Veterinary Medicine Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Veterinary Medicine Advisory Committee. General Function of the Committee: To provide advice and recommendations to the agency on FDA’s regulatory issues. Date and Time: The meeting will be held on September 25, 2006, from 8:30 a.m. to 5 p.m. Location: DoubleTree Hotel, Plaza Rooms II–III, 1750 Rockville Pike, Rockville, MD. Contact Person: Aleta Sindelar, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240–276– 9004, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), code 3014512548. Please call the Information Line for up-to-date information on this meeting. Agenda: The committee will discuss and make recommendations on the microbial food safety of an antimicrobial drug application currently under review for use in food-producing animals in accordance with the Center for Veterinary Medicine’s guidance for industry #152. PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 48931 The background material for this meeting will be posted on the Internet no later than 1 business day before the meeting at http://www.fda.gov/cvm/ default.html. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before September 13, 2006. Oral presentations from the public will be scheduled between approximately 1 p.m. and 2 p.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before September 13, 2006. Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Aleta Sindelar at least 7 days in advance of the meeting. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: August 16, 2006. Randall W. Lutter, Associate Commissioner for Policy and Planning. [FR Doc. E6–13818 Filed 8–21–06; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Health Resources and Services Administration (HRSA) publishes abstracts of information collection requests under review by the Office of Management and Budget (OMB), in compliance with the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). To request a copy of the clearance requests submitted to E:\FR\FM\22AUN1.SGM 22AUN1 48932 Federal Register / Vol. 71, No. 162 / Tuesday, August 22, 2006 / Notices OMB for review, call the HRSA Reports Clearance Office on (301) 443–1129. The following request has been submitted to the Office of Management and Budget for review under the Paperwork Reduction Act of 1995: Proposed Project: Outcome Study of National Health Service Corps (NHSC) Chiropractor and Pharmacist Loan Repayment Demonstration Project— New In 2002, Congress authorized a demonstration project to provide for the participation of chiropractors and pharmacists in the NHSC Loan Repayment Program. This study provides for an evaluation of the demonstration project to determine (1) The manner in which the demonstration project has affected access to primary care services, patient satisfaction, quality of care, and health care services provided for traditionally underserved populations, (2) how the participation of chiropractors and pharmacists in the Loan Repayment Program might affect Average burden per response (in hours) Number of responses/ respondent Number of respondents Respondents the designation of health professional shortage areas, and (3) whether adding chiropractors and pharmacists as permanent members of the NHSC would be feasible and would enhance the effectiveness of the NHSC. The burden estimate is as follows: Total burden (in hours) Clinic Users ...................................................................................................... Chiropractors & Pharmacists ........................................................................... NHSC Site Administrative Personnel .............................................................. 2,000 60 30 1 1 1 .25 .50 .50 500 30 15 Total .......................................................................................................... 2,090 ........................ ........................ 545 Written comments and recommendations concerning the proposed information collection should be sent within 30 days of this notice to: John Kraemer, Human Resources and Housing Branch, Office of Management and Budget, New Executive Office Building, Room 10235, Washington, DC 20503. Dated: August 15, 2006. Cheryl R. Dammons, Director, Division of Policy Review and Coordination. [FR Doc. E6–13847 Filed 8–21–06; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [USCG–2006–25560] Head and Gut Fleet; Alternate Standards for Fish Processing Vessels Coast Guard, DHS. Notice of availability. AGENCY: cprice-sewell on PROD1PC66 with NOTICES ACTION: SUMMARY: The Coast Guard announces the availability of a policy letter detailing the Coast Guard’s determination that ‘‘head and gut fleet’’ vessels constitute fish processing vessels for regulatory purposes. For vessels that, because of their age, cannot comply with certain regulatory requirements, an exemption from those requirements will be granted if the vessel owner proposes an acceptable alternative that provides a level of safety that is equivalent to the current regulations. VerDate Aug<31>2005 15:34 Aug 21, 2006 Jkt 208001 If you have questions on this notice, contact Mr. Michael Rosecrans, Chief, Fishing Vessel Safety Division, Commandant (G-PCV–3), telephone 202–372–1245, or by e-mail at MRosecrans@comdt.uscg.mil. If you have questions on viewing or submitting material to the docket, call Ms. Renee V. Wright, Program Manager, Docket Operations, telephone 202–493–0402. SUPPLEMENTARY INFORMATION: FOR FURTHER INFORMATION CONTACT: Background and Purpose In the process of investigating the loss of the fishing vessels GALAXY and ARCTIC ROSE, the Coast Guard became aware of a class of approximately 65 vessels known as the ‘‘head and gut fleet.’’ This fleet involves two basic vessel types, freezer trawlers and freezer longliners. These vessels operate in the Gulf of Alaska and the Bering Sea/ Aleutian Island fisheries. They catch fish and perform a number of operations, including freezing and packaging the catch for later distribution to a number of foreign and domestic markets. Some of the operations conducted on board exceed the operations permitted for fishing vessels. Title 46 U.S. Code 2101(11b) defines a ‘‘fish processing vessel’’ as ‘‘a vessel that commercially prepares fish or fish products other than by gutting, decapitating, gilling, skinning, shucking, icing, freezing or brine chilling.’’ The Coast Guard has determined that the operations conducted on board this fleet of vessels qualify the vessels as fish processing vessels. Coast Guard regulations in 46 CFR 28.710 require a PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 fishing processing vessel to be classed by the American Bureau of Shipping or a similarly qualified organization, and under 46 CFR 42.03–5, a fish processing vessel of a certain size must also obtain a Load Line Certificate. Due to the age of the majority of the vessels in this fleet, they are ineligible to enter class with the American Bureau of Shipping or a similarly qualified organization. As a result, the Coast Guard has developed a policy to address safety concerns by permitting exemptions from the aforementioned regulations, as authorized by 46 CFR 28.60, provided the owner of a vessel proposes alternatives to the required regulations that provide a level of safety that is equivalent to the current regulations. This decision is documented in GPCV Policy Letter 06–03. It may be viewed on-line at http://www.uscg.mil/ hq/g-m/moc/docs.htm. Dated: August 17, 2006. Howard L. Hime, Acting Director of National and International Standards, Assistant Commandant for Prevention. [FR Doc. E6–13902 Filed 8–21–06; 8:45 am] BILLING CODE 4910–15–P E:\FR\FM\22AUN1.SGM 22AUN1

Agencies

[Federal Register Volume 71, Number 162 (Tuesday, August 22, 2006)]
[Notices]
[Pages 48931-48932]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-13847]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Health Resources and Services Administration 
(HRSA) publishes abstracts of information collection requests under 
review by the Office of Management and Budget (OMB), in compliance with 
the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). To request 
a copy of the clearance requests submitted to

[[Page 48932]]

OMB for review, call the HRSA Reports Clearance Office on (301) 443-
1129.
    The following request has been submitted to the Office of 
Management and Budget for review under the Paperwork Reduction Act of 
1995:

Proposed Project: Outcome Study of National Health Service Corps (NHSC) 
Chiropractor and Pharmacist Loan Repayment Demonstration Project--New

    In 2002, Congress authorized a demonstration project to provide for 
the participation of chiropractors and pharmacists in the NHSC Loan 
Repayment Program. This study provides for an evaluation of the 
demonstration project to determine (1) The manner in which the 
demonstration project has affected access to primary care services, 
patient satisfaction, quality of care, and health care services 
provided for traditionally underserved populations, (2) how the 
participation of chiropractors and pharmacists in the Loan Repayment 
Program might affect the designation of health professional shortage 
areas, and (3) whether adding chiropractors and pharmacists as 
permanent members of the NHSC would be feasible and would enhance the 
effectiveness of the NHSC.
    The burden estimate is as follows:

--------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
                   Respondents                      respondents     responses/     response (in     (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Clinic Users....................................           2,000               1             .25             500
Chiropractors & Pharmacists.....................              60               1             .50              30
NHSC Site Administrative Personnel..............              30               1             .50              15
                                                 ---------------------------------------------------------------
    Total.......................................           2,090  ..............  ..............             545
----------------------------------------------------------------------------------------------------------------

    Written comments and recommendations concerning the proposed 
information collection should be sent within 30 days of this notice to: 
John Kraemer, Human Resources and Housing Branch, Office of Management 
and Budget, New Executive Office Building, Room 10235, Washington, DC 
20503.

    Dated: August 15, 2006.
Cheryl R. Dammons,
Director, Division of Policy Review and Coordination.
[FR Doc. E6-13847 Filed 8-21-06; 8:45 am]
BILLING CODE 4165-15-P